Definition |
The phenomenon of an increase in urinary Na+ excretion (UNaV) following the initial increase in Na+ reabsorption and retention caused by aldosterone. UNaV increases back to baseline levels that occurs despite continued aldosterone action. |
The lack of continuing suppression of the renin-angiotensin-aldosterone system (RAAS) despite treatment with RAAS blockers. Plasma aldosterone returns to previously unsuppressed and elevated baseline values, exhibiting a “breakthrough” from the suppression. |
Mechanisms behind phenomena |
Increasing renal perfusion pressure
Volume expansion
Decreased proximal Na+ reabsorption
Increased Na+ delivery to distal nephron
Inhibition of distal Na+ reabsorption
|
|
Disease state/treatment that induces phenomena |
Primary hyperaldosteronism |
Treatment with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) in patients with hypertension, chronic kidney disease, or chronic heart failure. |